Optimal Methods to Characterize ADC Resistance in Solid Tumors and Identify Clinically Useful Biomarkers

Clinical trial NCT07259226 · RECRUITING

Trial details

NCT number: NCT07259226
Sponsor: UNICANCER
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Breast Cancer Advanced Gastric Cancer Advanced Urothelial Cancer Advanced Non Small Cell Lung Cancer (NSCLC)

Start date: 2025-11-14
Primary completion: 2030-11-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.